Primary Hyperlipidaemia
Primary Hyperlipidaemia is a condition in which cholesterol or triglyceride levels in the blood are elevated. It can be present from birth or develop over time, raising the long-term risk of cardiovascular disease.
Key points
- Primary Hyperlipidaemia can be inherited or develop alongside factors such as diet, inactivity, or certain medical conditions.
- Treatment aims to lower cholesterol or triglyceride levels and reduce the risk of cardiovascular disease over time.
- The condition is long-term and usually requires ongoing monitoring of lipid levels and cardiovascular risk.
Medicines listed for Primary Hyperlipidaemia
The listed products include two statins and one cholesterol absorption inhibitor. Pitavastatin and Rosuvastatin are statins that lower cholesterol by reducing its production in the body. Ezetimibe is a cholesterol absorption inhibitor that limits the uptake of cholesterol in the gut. The two listed products are Livalo (pitavastatin 1 mg and 4 mg tablet) and Roszet (rosuvastatin 40 mg and ezetimibe 10 mg tablet).

